IRBESARTAN AND HYDROCHLOROTHIAZIDE

Generic: IRBESARTAN AND HYDROCHLOROTHIAZIDE

Teva Pharmaceuticals USAManufacturer
ORALRoute
IRBESARTANActive Substance
2012-03-30Original Approval

IRBESARTAN AND HYDROCHLOROTHIAZIDE is FDA application ANDA077369, sponsored by TEVA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Recalls

Top Reported Reactions

1
DIZZINESS
67 reports
2
FATIGUE
61 reports
3
HYPONATRAEMIA
60 reports
4
NAUSEA
51 reports
5
DRUG INEFFECTIVE
47 reports
6
MALAISE
47 reports
7
VOMITING
45 reports
8
DYSPNOEA
44 reports
9
FALL
44 reports
10
ASTHENIA
41 reports